RVNC
Revance Therapeutics, Inc.
RVNC
RVNC
Delisted
RVNC was delisted on the 5th of February, 2025.
101 hedge funds and large institutions have $734M invested in Revance Therapeutics, Inc. in 2018 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 34 increasing their positions, 30 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
14% less capital invested
Capital invested by funds: $854M → $734M (-$120M)
40% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 20
Holders
101
Holding in Top 10
2
Calls
$944K
Puts
$466K
Top Buyers
| 1 | +$8.58M | |
| 2 | +$7.96M | |
| 3 | +$5.96M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.78M |
| 5 |
JP Morgan Chase
New York
|
+$3.19M |
Top Sellers
| 1 | -$5.3M | |
| 2 | -$4.81M | |
| 3 | -$2.17M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$2.11M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$2.08M |